Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,005 | -1,777 | -1,112 | -462 | -1,260 |
| Depreciation Amortization | 387 | 303 | 283 | 62 | 287 |
| Accounts payable and accrued liabilities | 24 | 17 | 25 | 28 | 15 |
| Other Working Capital | -34 | -3 | -17 | 35 | 75 |
| Other Operating Activity | 853 | 239 | 140 | 63 | 53 |
| Operating Cash Flow | $-1,774 | $-1,221 | $-682 | $-274 | $-830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -20 | -3 | -3 | -11 |
| Investing Cash Flow | $-29 | $-20 | $-3 | $-3 | $-11 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250 | 250 | 250 | 200 | 925 |
| Common Stock Issued | 1,865 | 1,465 | 1,465 | N/A | N/A |
| Other Financing Activity | -55 | -55 | -55 | 0 | 0 |
| Financing Cash Flow | $2,060 | $1,660 | $1,660 | $200 | $925 |
| Beginning Cash Position | 84 | 84 | 84 | 84 | N/A |
| End Cash Position | 341 | 503 | 1,060 | 7 | 84 |
| Net Cash Flow | $257 | $419 | $976 | $-77 | $84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,774 | -1,221 | -682 | -274 | -830 |
| Capital Expenditure | -29 | -20 | -3 | -3 | -11 |
| Free Cash Flow | -1,804 | -1,241 | -684 | -277 | -841 |